| Bioactivity | Anagrelide hydrochloride monohydrate is a imidazoquinazoline agent. Anagrelide hydrochloride monohydrate decreases the level of platelets in blood, prevents blood clots formation. Anagrelide hydrochloride monohydrate can be used for research of essential thrombocythaemia (ET) and thrombocythaemia associated with polycythaemia vera (PV)[1]. |
| Name | Anagrelide hydrochloride monohydrate |
| CAS | 823178-43-4 |
| Formula | C10H10Cl3N3O2 |
| Molar Mass | 310.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pescatore SL, et al. Anagrelide: a novel agent for the treatment of myeloproliferative disorders. Expert Opin Pharmacother. 2000 Mar;1(3):537-46. [2]. Mahajan R, et al. Phosphodiesterase inhibitors and their role in therapeutics[J]. Journal of Research in Medical Education & Ethics, 2013, 3(2): 115-123. |
Anagrelide hydrochloride monohydrate
CAS: 823178-43-4 F: C10H10Cl3N3O2 W: 310.56
Anagrelide hydrochloride monohydrate is a imidazoquinazoline agent. Anagrelide hydrochloride monohydrate decreases the l
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.